Detalhe da pesquisa
1.
Prevalence of baseline NS3 resistance-associated substitutions (RASs) on treatment with protease inhibitors in patients infected with HCV genotype 1.
Clin Res Hepatol Gastroenterol
; 43(6): 700-706, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30880098
2.
Treatment of chronic HCV infection with DAAs in Rio de Janeiro/Brazil: SVR rates and baseline resistance analyses in NS5A and NS5B genes.
PLoS One
; 14(5): e0216327, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31063475